No Data
Precigen, Inc. (NASDAQ:PGEN) Surges 21%; Private Equity Firms Who Own 36% Shares Profited Along With Institutions
Key Insights Significant control over Precigen by private equity firms implies that the general public has more power to influence management and governance-related decisions 51% of the business
Precigen Insiders Added US$1.72m Of Stock To Their Holdings
Precigen (NASDAQ:PGEN) Shareholders Are up 15% This Past Week, but Still in the Red Over the Last Three Years
Stifel Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $10
Stifel analyst Benjamin Burnett maintains $Precigen(PGEN.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 35.3% and a total a
Express News | JMP Securities Reiterates Market Outperform on Precigen, Maintains $14 Price Target
Precigen (NASDAQ:PGEN) Adds US$50m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 78%
Precigen, Inc. (NASDAQ:PGEN) shareholders should be happy to see the share price up 15% in the last week.